PLSE
Income statement / Annual
Last year (2023), Pulse Biosciences, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Pulse Biosciences, Inc.'s net income was -$42.21 M.
See Pulse Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00
|
$700,000.00
|
$1.42 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$1.21 M |
$11.94 M |
$1.97 M |
$665,000.00 |
$666,000.00 |
$665,000.00 |
$665,000.00 |
$665,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$1.21 M |
-$11.24 M |
-$550,000.00 |
-$665,000.00 |
-$666,000.00 |
-$665,000.00 |
-$665,000.00 |
-$665,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
-16.06 |
-0.39 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$27.80 M
|
$20.84 M
|
$28.64 M
|
$26.44 M
|
$24.96 M
|
$17.25 M
|
$9.65 M
|
$5.99 M
|
$2.58 M
|
$44,571.00
|
| General & Administrative
Expenses |
$15.78 M
|
$13.96 M
|
$19.07 M
|
$22.86 M
|
$22.33 M
|
$20.05 M
|
$15.50 M
|
$2.93 M
|
$1.22 M
|
$73,714.00
|
| Selling & Marketing
Expenses |
$0.00
|
$12.02 M
|
$14.75 M
|
$7.26 M
|
$5.86 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$15.78 M
|
$25.97 M
|
$33.82 M
|
$22.86 M
|
$22.33 M
|
$20.05 M
|
$15.50 M
|
$2.93 M
|
$1.22 M
|
$73,714.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$665,000.00 |
$666,000.00 |
-$28,000.00 |
$665,000.00 |
$665,000.00 |
$665,393.00 |
$0.00 |
| Operating Expenses |
$43.57 M |
$46.81 M |
$62.46 M |
$49.97 M |
$47.95 M |
$37.96 M |
$25.81 M |
$9.59 M |
$4.47 M |
$514,286.00 |
| Cost And Expenses |
$43.57 M |
$58.76 M |
$64.43 M |
$49.97 M |
$47.95 M |
$37.96 M |
$25.81 M |
$9.59 M |
$4.47 M |
$514,286.00 |
| Interest Income |
$0.00 |
$263,000.00 |
$646,000.00 |
$114,000.00 |
$983,000.00 |
$446,000.00 |
$247,000.00 |
$68,000.00 |
$0.00 |
$0.00 |
| Interest Expense |
$1.36 M |
$448,000.00 |
$646,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.21 M
|
$1.36 M
|
$1.15 M
|
$1.10 M
|
$1.16 M
|
$1.31 M
|
$1.00 M
|
$759,000.00
|
$716,984.00
|
$200,571.00
|
| EBITDA |
-$42.37 M
|
-$56.70 M
|
-$61.87 M
|
-$48.87 M
|
-$46.79 M
|
-$36.65 M
|
-$24.57 M
|
-$8.83 M
|
-$3.75 M
|
-$108,000.00
|
| EBITDA Ratio |
0 |
-82.94 |
-44.44 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
-82.94
|
-44.44
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.36 M
|
-$448,000.00
|
-$646,000.00
|
$114,000.00
|
$983,000.00
|
$418,000.00
|
$247,000.00
|
$68,000.00
|
$0.00
|
-$396,001.00
|
| Income Before Tax |
-$42.21 M |
-$58.51 M |
-$63.66 M |
-$49.85 M |
-$46.97 M |
-$37.55 M |
-$25.57 M |
-$9.52 M |
-$4.47 M |
-$514,286.00 |
| Income Before Tax Ratio
|
0
|
-83.58
|
-44.89
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$448,000.00 |
-$500,000.00 |
-$114,000.00 |
-$983,000.00 |
-$28,000.00 |
-$912,000.00 |
-$94,000.00 |
-$1.66 M |
$39,429.00 |
| Net Income |
-$42.21 M |
-$58.95 M |
-$63.16 M |
-$49.74 M |
-$45.99 M |
-$37.55 M |
-$25.57 M |
-$9.52 M |
-$2.81 M |
-$474,857.00 |
| Net Income Ratio |
0 |
-84.22 |
-44.54 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.88 |
-1.74 |
-2.26 |
-2.14 |
-2.22 |
-2.2 |
-1.73 |
-0.86 |
-0.37 |
-0.19 |
| EPS Diluted |
-0.88 |
-1.74 |
-2.26 |
-2.14 |
-2.22 |
-2.2 |
-1.73 |
-0.86 |
-0.37 |
-0.19 |
| Weighted Average Shares
Out |
$48.04 M
|
$33.94 M
|
$27.96 M
|
$23.25 M
|
$20.75 M
|
$17.08 M
|
$14.75 M
|
$11.01 M
|
$7.57 M
|
$2.51 M
|
| Weighted Average Shares
Out Diluted |
$48.04 M
|
$33.94 M
|
$27.96 M
|
$23.25 M
|
$20.75 M
|
$17.08 M
|
$14.75 M
|
$11.01 M
|
$7.57 M
|
$2.51 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
